Targeted transarterial therapy of Vx-2 rabbit liver tumor with Yttrium-90 labeled ferromagnetic particles using an external magnetic field

Anticancer Research

Volumn 27, Issue 2, 2007, Pages 755-760

  Kobeiter, Hicham ^a   Georgiades, Christos S ^b   Leakakos, Tina ^c   Torbenson, Michael ^b   Hong, Kelvin ^b   Geschwind, Jean Francois ^b  

^a HENRI MONDOR HOSPITAL   (France)

^b JOHNS HOPKINS HOSPITAL   (United States)

^c AuRx Inc   (United States)

Author keywords

Liver cancer; Radioembolization; Transarterial chemoembolization; Yttrium 90

Indexed keywords

FERROMAGNETIC MATERIAL; FERROMAGNETIC MATERIAL Y 90; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; ISOTOPE LABELING; LIVER CELL CARCINOMA; LIVER TUMOR; MAGNETIC FIELD; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RADIATION DOSE; RADIOACTIVITY; TUMOR NECROSIS;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, RADIATION; EMBOLIZATION, THERAPEUTIC; FERRIC COMPOUNDS; HEPATIC ARTERY; LIVER NEOPLASMS, EXPERIMENTAL; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETICS; MALE; NECROSIS; PARTICLE SIZE; RABBITS; RADIOPHARMACEUTICALS; TISSUE DISTRIBUTION; YTTRIUM RADIOISOTOPES;

EID: 34247103232     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Georgiades CS, Ramsey DE, Solomon SS and Geschwind JF: New non-surgical therapies in the treatment of hepatocellular carcinoma. Techniques Vasc Interv Rad 4(3): 193-199, 2001.
2. Salem R Thurston KG, Goin JE and Geschwind JF: Yttrium-90 microspheres: radiation therapy for unresectable liver cancer. J Vasc Interv Radiol 13: S223-229, 2002.
3. 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients. Liver Transplantation 10(2)(Suppl 1): S107-S110, 2004.
4. Salem RL, Lewandowski R and Roberts C: Use of Yttrium-90 glass microspheres (Therasphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis. J Vasc Interv Radiol 15: 335-345, 2004.
5. Sarfaraz M, Kennedy AS, Cao ZJ et al: Physical aspects of Yttrium-90 microsphere therapy for nonresectable hepatic tumors. Med Phys 30(2): 199-203, 2003.